# Biovertis

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biovertis

- Industry: Pharmaceuticals
- Headquarters: Vienna, Austria
- Total disclosed funding: $27M
- Latest round: Series B (Dec 1, 2005)
- Investors on record: 3

## About

Biovertis AG is a biopharmaceutical company developing small molecule drugs against proprietary microbial antigens.

## Funding rounds

- Series B, Dec 1, 2005, $12M — TVM Capital Life Science, EQT Life Sciences, IKB Invest
- Series A, Sep 2, 2004, $15M — TVM Capital Life Science

## Investors

- TVM Capital Life Science (https://capitalatlas.ai/funds/tvm-capital-life-science) — Series A, Series B
- EQT Life Sciences (https://capitalatlas.ai/funds/eqt-life-sciences) — Series B
- IKB Invest (https://capitalatlas.ai/funds/ikb-invest) — Series B